Study reveals a paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia

FHS
August 15, 2024
12:43 am

Researchers at Children’s Hospital of Philadelphia (CHOP), St. Jude Children’s Research Hospital (St. Jude) and the Children’s Oncology Group (COG) today announced a significant paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia (T-ALL), an aggressive and high-risk form of cancer, to one frequently driven by genetic changes in non-coding portions of our DNA.

Doctors in the U.S. can learn a lot about advocacy and activism from their Israeli counterparts

Israeli doctors are bracing for a fight. On Sept. 12, the Israeli Supreme Court is set to hear challenges to a core component of Prime

September 11, 2023

Medtronic’s ablation sales slowed by PFA supply issues

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q2 FY2025 revenue: $8.4

November 19, 2024

Opinion | ‘We See Death as a Failure’: What We Heard This Week

“I think in medicine, just like in society, we see death as a failure — and we do everything we can to avoid failure.” —

November 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.